Terlipressin Acetate
Terlipressin Acetate is a selective V1 receptor agonist studied for its protective effects against OGD/R-induced injury in IEC-6 cells, demonstrating anti-inflammatory and antioxidant properties. Its research applications include investigations into hepatorenal syndrome and catecholamine-resistant septic shock, utilizing both in vitro and preclinical in vivo models.
Product Specifications
Product Name Alternative
Anti-oxidative, bleeding, Terlipressin, Terlipressin Acetate, Terlipressin acetate anhydrous, V1-receptors, variceal, vasoconstriction, Vasopressin Receptor, VasopressinReceptor, vasopressin V1
Field of Research
Pharmacology & Drug Discovery
Purity
98.50% (May vary between batches)
Solubility
DMSO:95 mg/mL (70.5 mM)
Molecular Weight
1347.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY431170 100 µg
ST6GALNAC3 (NM_001160011) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRV-0058577-01 20 µL
Polyclonal Antibody to Bcl2 Associated Athanogene 1 (BAG1)
Sign In for Pricing
View Details TRV-0058577-02 100 µL
Polyclonal Antibody to Bcl2 Associated Athanogene 1 (BAG1)
Sign In for Pricing
View Details TRV-0058577-03 200 µL
Polyclonal Antibody to Bcl2 Associated Athanogene 1 (BAG1)
Sign In for Pricing
View Details TRV-0058577-04 1 mL
Polyclonal Antibody to Bcl2 Associated Athanogene 1 (BAG1)
Sign In for Pricing
View Details